Business

Zydus Cadila gets USFDA nod to market generic tension headache tablets

The company has received final approval to market Butalbital, Acetaminophen and Caffeine tablets in strengths of 50mg/325mg/40 mg, Zydus Cadila said in a statement.

From our online archive

NEW DELHI: Drug firm Zydus Cadila on Saturday said it has received final approval from the US health regulator to market generic Butalbital, Acetaminophen and Caffeine combination tablets to treat symptoms of tension headaches.

The company has received final approval from the United States Food and Drug Administration (USFDA) to market Butalbital, Acetaminophen and Caffeine tablets in strengths of 50mg/325mg/40 mg, Zydus Cadila said in a statement.

The drug will be manufactured at Nesher Pharma's manufacturing facility at St.Louis in the US, it added.

This combination medication is used to treat symptom complex of tension (or muscle contraction) headaches, Zydus Cadila said.

The group now has 294 approvals and has filed over 390 abbreviated new drug applications (ANDAs) since the commencement of the filing process, it added.

The war that has not been won by anyone

BJP leader Amarinder Singh’s presence at Sonia Gandhi’s book launch fuels speculation ahead of Punjab polls

COP31: India seeks global mechanism for just transition, urges developed nations to share clean energy costs

Rohit Pawar accuses Fadnavis of protecting aircraft firm owner in Ajit Pawar crash probe; BJP hits back

From Cambridge courtship to India Gate dates, Sonia Gandhi recalls her early years with Rajiv